RFA
XERS icon

RTD Financial Advisors’s Xeris Biopharma Holdings XERS Stock Holding History

RTD Financial Advisors’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-12,957
Closed -$20K – 96
2022
Q3 		$20K Hold
12,957
– – ﹤0.01% 92
2022
Q2 		$20K Hold
12,957
– – ﹤0.01% 108
2022
Q1 		$33K Hold
12,957
– – ﹤0.01% 112
2021
Q4 		$38K Buy
+12,957
New +$28K 0.01% 116

Other funds holding XERS

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

RTD Financial Advisors's XERS Position: Q4 2022 in Review

RTD Financial Advisors sold out of Xeris Biopharma Holdings (XERS) in Q4 2022, closing a stake of 12,957 shares — an estimated $20K sold.

RTD Financial Advisors first reported a position in XERS in Q4 2021 and held it in 4 quarters. The position peaked at $38K in Q4 2021. 97 funds tracked by Wall St. Rank hold XERS as of Q4 2022.

  • RTD Financial Advisors reported no remaining Xeris Biopharma Holdings position as of Q4 2022 after selling out during the quarter.
  • RTD Financial Advisors sold 12,957 Xeris Biopharma Holdings shares in Q4 2022, an estimated $20K.
  • RTD Financial Advisors first reported a position in Xeris Biopharma Holdings in Q4 2021 and held it in 4 quarters.
  • RTD Financial Advisors's Xeris Biopharma Holdings position peaked at $38K in Q4 2021.
  • 97 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q4 2022.

Based on RTD Financial Advisors's 13F filing for Q4 2022, filed 24 Jan 2023.